The function and mechanism of PSMD14 in promoting progression and resistance to anlotinib in osteosarcoma

Table 2 Univariate logistic regression analysis of risk factors affecting overall survival

Clinicopathological features	Univariate logistic regression
Clinicopathological features	HR	95% CI	P
Gender (male vs. female)	0.570	0.227–1.433	0.232
Age (≥ 18 vs. < 18 岁)	1.700	0.672–4.300	0.262
Site (limb vs. other^b)	2.479	0.590–10.423	0.215
Histopathologic type (classic vs. other^a)	3.581	0.674–19.020	0.134
Pathological fracture (yes vs. no)	1.500	0.387–5.810	0.557
Operation (amputation vs. limb salvage)	1.768	0.560–5.579	0.331
Pathological grade (high vs. moderate/low)	5.946	1.190–29.716	0.030
Enneking stage (III vs. IIA/IIB)	6.375	1.891–21.496	0.003
PSMD14 expression (high vs. low)	5.806	1.966–17.142	0.001

^aPeriosteal osteosarcoma, paracortical osteosarcoma, telangiectatic osteosarcoma
^bSpine, pelvis, skull, scapula, etc.

ISSN: 1475-2867